Search

everythinglearnresearchcommunity

for

Search:↓

PRGF treatment is safer and more effective for hair loss than topical minoxidil.

Vav2 and Vav3 proteins help control skin stem cell numbers and activity in both healthy and cancerous cells.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

Activating Wnt in skin cells controls the number of hair follicles by directing cell movement and fate.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Most people in Alahsa, Saudi Arabia, have low awareness of thyroid disease symptoms and risk factors.

BMPs are crucial for hair growth and their decrease by androgens leads to hair loss.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

AGA patients have higher heart disease risk.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Higher IL-17A levels indicate more severe alopecia areata.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

Vitamin D receptor is crucial for starting hair growth after birth.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Protein extract from embryonic skin can create new hair follicles in adult life, primarily through effects on fibroblasts.

Too much epidermal growth factor can cause hair loss.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

EGF controls hair growth by regulating hair follicles' growth phases.

Cancer development is like natural selection, involving mutated cells and environmental factors.